Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2 - A Continuation of the Multicenter Randomized Control Trial SEXTANT 1

NCT04678154 is registered in ClinicalTrials.gov with Major Extremity Trauma Research Consortium as lead sponsor.

NCT NCT04678154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04678154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2 - A Continuation of the Multicenter Randomized Control Trial SEXTANT 1
Lead sponsor
Major Extremity Trauma Research Consortium
Phase
Phase 3
Overall status
Recruiting
Start date
May 7, 2021
Completion date
March 31, 2029
Enrollment
600 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

post operative surgical site infection